Publication | Closed Access

Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer

NanoparticlesNanomedicineSurvivin SirnaEngineeringNanomaterialsNanotechnologyPolymer-drug ConjugateTherapeutic NanomaterialsPharmaceutical NanotechnologyPlatinum-resistant Lung CancerNano-drug DeliveryBiomedical EngineeringPharmacologyRadiation Oncology